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Abstract
Background: Cryotherapy is a safe, affordable, and effective method of treatment for cervical
intraepithelial neoplasia. In some low-resource settings, environmental conditions or qualities of
the refrigerant gas can lead to blockage of cryotherapy equipment, terminating treatment. A
prototype of a gas conditioner to prevent operational failure was designed, built, and field tested.
Methods: The prototype conditioner device consists of an expansion chamber that filters and
dries the refrigerant gas. Users in Peru and Kenya reported on their experience with the prototype
conditioner. In Ghana, simulated cryotherapy procedures were used to test the effects of the
prototype conditioner, as well as the commonly used "cough technique."
Results:  Anecdotal reports from field use of the device were favorable. During simulated
cryotherapy, the prevalence of blockage during freezing were 0% (0/25) with the device alone,
23.3% (7/30) with the cough technique alone, 5.9% (1/17) with both, and 55.2% (16/29) with neither
(Pearson's Chi square = 26.6, df = 3, p < 0.001 (comparison amongst all groups)).
Conclusion: This prototype design of a cryotherapy gas conditioner is a potential solution for
low-resource settings that are experiencing cryotherapy device malfunction.
Background
Cryotherapy to treat precancerous cervical lesions in low-
resource settings has been shown to be both clinically
effective and logistically possible [1-4]. However, experi-
ence in developing country clinics has indicated that cry-
otherapy units fail due to blockage (i.e. complete
stoppage of the gas flow), and that preventive measures
are advisable [5,6]. This problem arises when there is an
interruption in gas flow during the procedure, and results
in service disruption for several minutes while the unit
thaws and the blockage clears. It can be argued that such
interruptions might threaten the effectiveness of cryother-
apy, since the procedure usually entails two 3-minute
freezes, separated by a 5-minute interval to allow thawing
of the tissue [7]. Typically, failures have been attributed to
gas supply line blockages caused by gas impurities, con-
densation and freezing of water vapor, or formation of dry
ice in the gas supply lines.
JHPIEGO currently advocates a "freeze-clear-freeze tech-
nique (also known as the "cough" technique) to alleviate
blockages [5]. The cough technique involves briefly inter-
rupting freezing every 15 seconds by depressing the
defrost button for no more than one second and then
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resuming freezing. While potentially effective, the appli-
cability of this technique is limited because it can only be
used with a device incorporating an active defrost func-
tion (e.g., Wallach LL100, Wallach Surgical Devices,
Orange, Connecticut) and cannot be used with other
devices (e.g., Ascon Multi Tip Cryo MTC-810, Ascon Med-
ical Instruments, Chennai, India) that do not have this
function. This paper describes the design and construction
of a prototype of an inexpensive gas conditioner device,
and assesses its field performance in low-resource settings.
In clinic settings in two countries using N2O and CO2 as
the refrigerant gas, anecdotal reports of effectiveness were
obtained from clinicians. In a third setting, evaluations
were conducted on nonhuman tissue with CO2, compar-
ing the prevalence of blockage with and without the con-
ditioner device and use of the cough technique.
Methods
Device design and construction
The prototype device was designed to address the hypoth-
esized reasons for cryotherapy device failure due to gas
blockage: the presence of liquid refrigerant and subse-
quent formation of dry ice, excessive moisture in the gas
leading to ice formation, and foreign matter. The device
functions as an expansion chamber (converting any liquid
refrigerant to gas), a gas dryer to remove excess moisture,
and a large-pore filter to remove any large particulate con-
taminants.
The conditioner (Figures 1 and 2) is constructed from off-
the-shelf materials and requires minimal assembly. The
main body is constructed from Schedule 80 pipe and fit-
tings, which are rated at 3000 pounds per square inch
(psi) to ensure an engineering design factor of three to
four for safety (tanks typically provide gas at 750 – 1000
psi). The prototype conditioner was constructed with gas
fittings appropriate for US N2O or CO2 gas cylinders (CGA
326 or 320) but can be designed with fittings appropriate
for the country in which the device is used. The desiccat-
ing material used in the conditioner is Drierite (W.A.
Hammond Drierite Co. Ltd., Xenia, Ohio), a commer-
cially available calcium sulfate laboratory desiccant, com-
monly used to dry laboratory gases. This desiccant can be
heated in a warm oven to restore its properties and allow
for extended use. The weight of an assembled device is 4.4
kg and measures 42 cm long, 22 cm wide, and 5.5 cm
high. The total cost of the conditioner is currently less
than $40 using components purchased at small-quantity
retail prices. A detailed view is shown in Figure 3 and a list
of materials, procured in the United States, is found in
Table 1. All conditioners were constructed and tested for
safety and functionality at PATH's product development
facility in Seattle, Washington. Because of the high gas
pressure required for operation of the cryotherapy device,
there are safety concerns associated with introduction of
an auxiliary device between the gas supply tank and the
cryotherapy device. If inferior materials are used to con-
struct the conditioner, prolonged blockage due to satu-
rated desiccant or other mechanical blockage could lead
to catastrophic failure of the conditioner.
Survey of clinicians in Kenya and Peru
The planned evaluations of the prototype were considered
by the PATH human subjects protection committee and
deemed to be acceptable. After the initial bench evalua-
tion at PATH, conditioners were distributed to three rural
field clinics in Kenya using Wallach LL100 and Ascon
MTC-810 cryotherapy units with N2O and one in Peru
Table 1: List of materials for the cryotherapy gas conditioner prototype. A list of materials for the cryotherapy gas conditioner 
prototype in which item numbers correspond to the parts in Figure 3. Manufacturer or distributor information and part number is 
included where possible.
ITEM NO. QUANTITY DESCRIPTION
1 1 HEX HEAD PLUG (1" NPT) [MCMASTER 4513K326]
2 1 COUPLING (1" NPT; 1.75" OD) [MCMASTER-CARR 4513K65]
3 1 SCHEDULE 80 1" × 3" NIPPLE [MCMASTER-CARR 7727K255]
4 1 TEE (1" NPT; 2.25" OD) [MCMASTER-CARR 4513K45]
5 1 SCHEDULE 80 1" × 6" NIPPLE [MCMASTER-CARR 7727K261]
6 1 90° ELBOW (1" NPT; 2.25" OD) [MCMASTER-CARR 4513K15]
7 2 SCOTCHBRITE PAD
8 2 ALUMINUM SCREEN
9 2 1" × 1/2" NPT HEX BUSHING [MCMASTER-CARR 4513K348]
10 2 1/2" × 1/4" NPT HEX BUSHING [MCMASTER-CARR 4513K344]
11 1 CGA 320 TO 1/4" NPT [WESTERN ENTERPRISES B-20]
12 2 FLAT TEFLON WASHER [WESTERN ENTERPRISES CO-6]
13 1 1/4" NPT NIPPLE [WESTERN ENTERPRISES CO-4]
14 1 CGA-320 NUT [WESTERN ENTERPRISES C0-2]
15 N/A DRIERITE DESICCANT (NOT SHOWN)
16 N/A TEFLON PIPE TAPE (NOT SHOWN)BMC Women's Health 2006, 6:2 http://www.biomedcentral.com/1472-6874/6/2
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using the Wallach LL100 unit with CO2. Since all of these
sites had reported problems with equipment blockage, it
was our intention to assess whether providers felt that the
use of the conditioners was associated with a decrease in
the occurrence of cryotherapy equipment failure due to
blockage. No systematic data were collected from these
sites, only the general observations of the providers.
Testing of the conditioner in Ghana
In order to quantify an effect that the conditioner might
have on the ability to prevent equipment failure, we initi-
ated a field study in May 2004 during a cryotherapy train-
ing session conducted by JHPIEGO in Ghana. During the
training, one of the investigators (F.B.) performed mock
cryotherapy treatments on beef sausage meat as surrogate
tissue using one Wallach LL100 cryotherapy unit and bev-
erage grade CO2 as the refrigerant gas. A fresh portion of
meat sausage was frozen for periods of either 3 or 5 min-
utes and the time interval between consecutive freezing
periods was varied from 5 to 20 minutes in 5-minute
intervals. A non-randomized, comparative study on the
prevalence of blockage of the cryotherapy device was con-
ducted by alternating the use of the conditioner and the
cough technique such that approximately one quarter of
the freezes were done with the conditioner and without
the cough technique, one quarter were done without the
conditioner and with the cough technique, one quarter
were done with both the conditioner and the cough tech-
nique, and one quarter were done with neither. The total
number of simulated procedures was 101 and the order of
times (3 or 5 minutes) and sequence of use of the four
combinations of methods were performed in a non-ran-
dom fashion. During the five-day evaluation period, F.B.
alternately used the four different methods and recorded
data on the ambient temperature, duration of freeze, time
since the previous freeze, and occurrence of blockage.
Differences in the prevalence of cryotherapy failure due to
blockage were compared using the chi-square test. A test
for an interaction between the cough technique and con-
ditioner in predicting blockage was done using binary
logistic regression with both techniques and an interac-
tion term in the model. Differences were considered sta-
tistically significant at p < 0.05. Analyses were done using
SPSS version 12 (SPSS, Chicago, Illinois).
Results
Survey of clinicians in Kenya and Peru
Users of the conditioner devices in Kenya and Peru con-
sistently reported that there were markedly fewer device
failures due to blockage during cryotherapy while using
the conditioner device. Providers who were using the
Wallach LL100 cryotherapy unit also reported that prior
A picture of the cryotherapy gas conditioner with an Ascon  Cryosurgery device Figure 2
A picture of the cryotherapy gas conditioner with an Ascon 
Cryosurgery device.
A sketch of the cryotherapy gas conditioner device Figure 1
A sketch of the cryotherapy gas conditioner device. Sketch 
represents gas conditioner device attached to the tank of 
refrigerant gas with the cryotherapy unit connected to the 
other end of the gas conditioner.BMC Women's Health 2006, 6:2 http://www.biomedcentral.com/1472-6874/6/2
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to the use of the conditioner devices, their experiences
were that the cough technique was not a reliable method
to prevent blockage. There was a general impression that
the time to achieve freezing of cervical tissue was reduced
with the conditioner device.
Testing of the conditioner in Ghana
Ambient evaluation temperature in Ghana varied
between 36° and 39°C (97° and 102°F), representative
of tropical clinic conditions. The anecdotal reports were
from Kenya and Peru were consistent with the impression
of the trainer (F.B.) during the experiments in Ghana.
Additionally, he indicated that there was more ice crystal
formation on the exterior of the cryotherapy device when
the conditioner was not used. The data on the prevalence
of blockage of the cryotherapy device under the four dif-
ferent conditions, using and not using the conditioner
and the cough technique, are summarized in Table 2. The
prevalence of cryotherapy device blockage during freezing
was 0% (0/25; 95% confidence interval 0% to 13.7%))
with the conditioner alone, 23.3% (7/30; 95% CI 9.9% to
42.3%) with the cough technique alone, 5.9% (1/17; 95%
CI 0.1% to 28.7%) with both the conditioner and the
cough technique, and 55.2% (16/29; 95% CI 35.7% to
73.6%) with neither (p < 0.001). Mean durations of freez-
ing periods attempted for the four conditions were com-
parable (Table 2).
In the binary logistic regression modeling, there was a sta-
tistically significant interaction effect (p < 0.05) suggest-
ing that the cough technique was significantly improved
when combined with the conditioner, but the main effect
of conditioner alone was as strong as the combined effect.
Predicted probabilities of blocking for the four combina-
tions from the regression model are shown in Figure 4.
Discussion
The use of the cryotherapy gas conditioner was associated
with a dramatic decrease in the rate of cryotherapy device
failure due to blockage, a rate reduction from 55.2% with-
out the device to zero with the device, when testing was
performed on non-human tissue. Because the exact reason
for cryotherapy device blockage is unknown, we are
unsure which of the proposed mechanisms of action are
An exploded view of the cryotherapy gas conditioner assembly Figure 3
An exploded view of the cryotherapy gas conditioner assembly.B
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Table 2: Data collected during simulated cryotherapy procedures in Ghana. Table represents the four conditions evaluated, the freeze duration, the time interval between 
freezing, and prevalence of blockage.
No cough technique or conditioner use Conditioner use without cough Cough technique without conditioner Conditioner and cough technique
Use 
sequence
Attempted 
freeze 
duration 
(minutes)
Time interval 
between 
freezing 
(minutes)
Blockage* Attempted 
freeze 
duration 
(minutes)
Time interval 
between 
freezing 
(minutes)
Blockage* Attempted 
freeze 
duration 
(minutes)
Time interval 
between 
freezing 
(minutes)
Blockage* Attempted 
freeze 
duration 
(minutes)
Time interval 
between 
freezing 
(minutes)
Blockage*
1 3 10 N 3 15 N 3 Multiple days N 5 5 N
23 5 Y3 5 N3 5 N5 5Y
35 1 5Y3 5 N5 5 Y3 5N
43 1 0N3 5 N3 1 0N3 5N
53 5 Y3 1 0N3 5 N3 1 0 N
63 1 0N3 5 N3 1 0N3 5N
73 5 Y3 1 0N3 5 Y3 1 0 N
85 2 0Y3 5 N5 7 2 0Y3 5N
9 3 15 N 5 10 N 3 20 N 5 10 N
10 3 5 N 3 10 N 3 5 Y 3 15 N
11 3 10 N 3 5 N 3 10 N 3 5 N
12 3 5 Y 5 10 N 3 5 N 3 10 N
13 3 10 N 5 10 N 5 600 N 3 5 N
14 3 5 Y 3 10 N 5 10 Y 3 5 N
15 3 10 N 3 5 N 3 15 N 3 5 N
16 3 5 Y 3 10 N 3 10 N 3 5 N
17 3 10 N 3 5 N 3 5 N 3 5 N
18 3 5 Y 3 10 N 3 10 N - - -
19 3 10 Y 3 5 N 3 5 N - - -
20 3 10 Y 3 10 N 3 10 N - - -
21 3 10 Y 3 5 N 3 5 N - - -
22 3 10 Y 3 1440 N 5 660 N - - -
23 3 10 Y 3 5 N 5 10 Y - - -
24 3 5 N 3 5 N 3 10 N - - -
25 3 5 Y 3 5 N 3 10 N - - -
26 3 10 N - - - 5 10 Y - - -
27 3 10 N - - - 3 5 N - - -
28 3 5 Y - - - 3 5 N - - -
29 3 5 N - - - 3 5 N - - -
30 - - - - - - 3 5 N - - -
Mean freezing time: 3.14 min
Failure prevalence: 16/29 (55.2%)
Mean freezing time: 3.25 min
Failure prevalence: 0/25 (0%)
Mean freezing time: 3.48 min
Failure prevalence: 7/30 (23.3%)
Mean freezing time: 3.35 min
Failure prevalence: 1/17(5.9%)
* Occurrence of blockage is denoted by Y, and lack of blockage by N.BMC Women's Health 2006, 6:2 http://www.biomedcentral.com/1472-6874/6/2
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responsible for the beneficial effect of the gas conditioner.
The high prevalence of failure during freezing without the
conditioner indicates that, in this setting, use of a gas con-
ditioner is preferred for consistency of cryotherapy service
delivery.
We are aware of only one article that refers to the use of a
similar device during cryotherapy procedures – in this
case a commercially available gas purifier, used to
improve consistency of cryotherapy operation during
research on the topography and depth of cervical cryole-
sions [8]. In its cryotherapy training materials, JHPIEGO
recognizes the existence of the problem in low-resource
settings and describes the cough technique as a preventive
measure for the problem of equipment blockage [5]. Our
anecdotal and quantitative data show that the cough tech-
nique is only partially effective, reducing the rate of block-
age from 55.2% to 23.3% during the mock procedures in
Ghana. The predictive model shows that there is an inter-
action between the conditioner device and the cough
technique, however the effect of the conditioner alone
was so strong that it is unlikely that the combined use of
the cough technique with the conditioner unit is justified.
Our study had several limitations. The non-randomized
order in which the various combinations of conditioner
unit and cough technique were used during the series of
freezes and the close spacing between simulated treat-
ments could have influenced the results in favor of the
conditioner device to some extent. The freezing periods
were often done in close succession which may increase
the likelihood of device blockage. Sample size was not cal-
culated a priori since there was not an estimate available
as to the effect size of the gas conditioner. The only gas
used in the Ghana study was beverage grade CO2 (an
intermediate grade between industrial and medical grade)
and it is not known if use of the more expensive, medical
grade of gas would have averted the problem of blockage.
The rates of cryotherapy failure in Kenya and Peru were
not systematically measured before use of the condi-
tioner, but instead the qualitative data were retrospective
and anecdotal. We have not established supply lines, local
cost of materials, or estimated times of delivery in coun-
tries outside of the U.S. The main strength of our evalua-
tion was that the studies were conducted in three
countries that experience problems with cryotherapy
equipment blockage.
One of the impediments to systematic bench research on
the problem of blockage has been the difference in failure
rates in low-resource settings compared to the rates found
either in developed-country clinics or in the laboratory.
Failure at the bench can be difficult to induce and may not
be entirely representative of the failure mechanism in a
low-resource clinic (e.g., introduction of water into the
supply gas line to mimic a hypothesized cause). Further
research regarding the use of the conditioner should focus
on four main areas. Confirmation is needed that, when
the conditioner is used, an equal or lesser time is required
to achieve an adequate ice ball on the cervix. Second, fur-
ther evaluation of ice ball depth and temperature is war-
ranted to ensure that the correct temperature and depth
are reached or exceeded with the use of the conditioner.
Third, the conditioner design could be refined to mini-
mize weight and size while still maintaining safety and
effectiveness. Lastly, it could be determined if the desic-
cant is necessary for adequate operation of the condi-
tioner. Without desiccant, the conditioner could still
provide an expansion chamber and filtering, lowering the
overall cost and complexity of the device.
Conclusion
This gas conditioning device shows potential to markedly
reduce cryotherapy device failures and improve service
delivery at clinics in low-resource settings that are experi-
encing this problem. Ideally, the conditioner will permit
the clinician to employ a continuous freeze method, with-
out the use of the cough technique, and provide adequate
service despite the use of low-quality gas or difficult envi-
ronmental conditions. The mechanism of beneficial
action of the conditioner is hypothesized to be the reduc-
tion of moisture in the gas, removal of particulate matter,
and elimination of liquid N2O or CO2 (via expansion and
conversion to a gas) before it enters the cryotherapy
device.
Predicted probabilities of cryotherapy equipment blockage Figure 4
Predicted probabilities of cryotherapy equipment blockage. 
Predicted probabilities of cryotherapy equipment blockage 
with and without the cryotherapy conditioner, and with and 
without use of the "cough" technique from the logistic 
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Additional information
Complete plans for construction of the cryotherapy gas
conditioner as presented in this article can be requested
from the author.
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